The Alberta Pre-Phase I Cancer Program (PP1P) is able to help investigators with their early stage cancer projects.
The Alberta Pre-Phase I Cancer Program (PP1P) was set up in 2013 by medical oncologist Dr. John Mackey and colleagues to link potential solutions with unmet needs. Both patients and clinicians are in urgent need of therapies that are safer and more effective. Alberta has a thriving discovery and medical research community, from which those therapies will spring. Linking problem with solution requires the translation of basic discovery research to clinical evaluation.
PP1P is located at the University of Alberta's Cross Cancer Institute (CCI) in Edmonton, Alberta. The Program is guided by a Steering Committee (below) with expertise in drug discovery, drug development and clinical oncology, and includes representation from the Alberta innovation community.